Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 9, 2009, Pages 1359-1360

  Stewart, Colin J R ^a   Hillery, Simon ^a   Plattell, Cameron ^a  

^a ST JOHN OF GOD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CARCINOMA; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; PERITONEUM METASTASIS; PRACTICE GUIDELINE; PROGNOSIS; SEROSA;

ADENOCARCINOMA; CLINICAL PROTOCOLS; COLORECTAL NEOPLASMS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATHOLOGY, SURGICAL; PERITONEUM;

EID: 69749099418     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Letter

References (22)

1. Washington MK, Berlin J, Branton PA, et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch Pathol Lab Med. 2008;132(7):1182-1193. (Pubitemid 351955745)
2. Sobin LH, Wittekind CH. UICC/TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
3. Jass JR, O'Brien MJ, Riddell RH, Snover DC. Recommendations for the reporting of surgically resected specimens of colorectal carcinoma. Hum Pathol. 2007;38(4):537-545.
4. Quirke P, Morris E. Reporting colorectal cancer. Histopathology. 2007;50(1):103-112.
5. Quirke P, Williams GT, Ectors N, Ensari A, Piard F, Nagtegaal I. The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol. 2007;8(7):651-657. (Pubitemid 46995637)
6. College of American Pathologists. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. http://www.cap.org/apps/docs/committees/cancer/ cancer-protocols/2008/ colonrectum08-pw.pdf. Accessed January 10, 2009.
7. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer. 2000;88(7):1739-1757. (Pubitemid 30183160)
8. Compton CC; for the Members of the Cancer Committee, College of American Pathologists. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Arch Pathol Lab Med. 2000; 124(7):1016-1025.
9. Compton CC; for the Members of the Cancer Committee, College of American Pathologists. Colon and rectum. In: Reporting on Cancer Specimens: Case Summaries and Background Documentation. Northfield, IL. College of American Pathologists; 2005.
10. Compton CC. Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol. 2003;16(4):376-388. (Pubitemid 36443987)
11. Compton CC. Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med. 2006; 130(3):318-324.
12. Goldstein NS. Recent pathology related advances in colorectal adenocarcinomas. Eur J Surg Oncol. 2001;27(5):446-450. (Pubitemid 32694596)
13. Lennon AM, Mulcahy HE, Hyland JMP, et al. Peritoneal involvement in stage II colon cancer. Am J Clin Pathol. 2003;119(1):108-113.
14. Newland RC, Dent OF, Lyttle MNB, Chapuis PH, Bokey EL. Pathological determinants of survival associated with colorectal cancer with lymph node metastases: a multivariate analysis of 579 patients. Cancer. 1994;73(8):2076-2082.
15. Newland RC, Dent OF, Chapuis PH, Bokey L. Survival after curative resection of lymph node negative colorectal carcinoma. Cancer. 1995;76(4): 564-571.
16. Shepherd NA, Baxter KJ, Love SB. Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol. 1995; 48(9):849-855.
17. Shepherd NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology. 1997;112(4):1096-1102.
18. Petersen VC, Baxter KJ, Love SB, Shepherd NA. Identification of objective pathological prognostic determinants and models of prognosis in Dukes' B colon cancer. Gut. 2002;51(1):65-69.
19. Stewart CJR, Morris M, De Boer B, Iacopetta B. Identification of serosal invasion and extramural venous invasion on review of Dukes' stage B colonic carcinomas and correlation with survival. Histopathology. 2007;51(3):372-378. (Pubitemid 47301625)
20. Stewart CJR, Hillery S, Havlat M. Serosal involvement in colorectal carcinoma. Histopathology. 2006;49(4):435-437.
21. Hermanek P, Henson DE, Hutter RVP, Sobin LH. TNM Supplement. New York, NY: Springer-Verlag; 1993.
22. Ludeman L, Shepherd NA. Serosal involvement in gastrointestinal cancer: its assessment and significance. Histopathology. 2005;47(2):123-131. (Pubitemid 41113114)